Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ainara Rodriguez-Marco

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|January 6, 2010
Autoimmunity and recurrent infections in partial complement C3 immunodeficiencyAinara Rodriguez-Marco, Mark Bradbury, Philip Riley, et al.
Plos One|March 19, 2014
Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in miceMa Paz Zafra, Carla Mazzeo, Cristina Gámez, et al.
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|January 6, 2010
Autoimmunity and recurrent infections in partial complement C3 immunodeficiencyAinara Rodriguez-Marco, Mark Bradbury, Philip Riley, et al.
Plos One|March 19, 2014
Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in miceMa Paz Zafra, Carla Mazzeo, Cristina Gámez, et al.
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
Pageof 1